Buserelin (Suprefact)

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 12:33, 4 December 2022 by Jwarner (talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Mechanism of action

Gonadotropin-releasing hormone (GnRH) analog, inhibits pituitary gonadotropin secretion, which suppresses ovarian and testicular steroidogenesis.

Diseases for which it is used

Prostate cancer

Also known as

Code names: HOE 766, ICI 123215, S74-6766
Brand names: Bigonist, Etilamide, Profact, Receptal, Suprecur, Suprefact

Retrieved from "https://hemonc.org/w/index.php?title=Buserelin_(Suprefact)&oldid=64910"